Acorah Software Products - Accounts Production 16.5.460 false true false true No description of principal activity 16 July 2024 31 July 2025 31 July 2025 15847481 Mr Anwar Miah iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15847481 2024-07-15 15847481 2025-07-31 15847481 2024-07-16 2025-07-31 15847481 frs-core:CurrentFinancialInstruments 2025-07-31 15847481 frs-bus:PrivateLimitedCompanyLtd 2024-07-16 2025-07-31 15847481 frs-bus:FilletedAccounts 2024-07-16 2025-07-31 15847481 frs-bus:Micro-entities 2024-07-16 2025-07-31 15847481 frs-bus:AuditExempt-NoAccountantsReport 2024-07-16 2025-07-31 15847481 frs-bus:Director1 2024-07-16 2025-07-31
Registered number: 15847481
Pharmaring Limited
Unaudited Financial Statements
For the Period 16 July 2024 to 31 July 2025
Rafique & Co
Chartered Certified Accountants
289 Bethnal Green Road
London
E2 6AH
Pharmaring Limited
Balance Sheet
As At 31 July 2025
Balance Sheet
Registered number: 15847481

| 31 July 2025
--- | ---
|  | £
Current assets |  | 8,096
Creditors: Amounts Falling Due Within One Year |  | (2,428 )
NET CURRENT ASSETS |  | 5,668
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 5,668
NET ASSETS |  | 5,668
CAPITAL AND RESERVES |  | 5,668

## Notes

1. General Information
Pharmaring Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15847481 . The registered office is Ztk Tax Advisory Suit 1, Ideas House, 18 Eastwood Close, London, E18 1BY.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Mr Anwar Miah Director
17/10/2025